92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer

International Journal of Cancer

Volumn 65, Issue 1, 1996, Pages 57-62

  Nielsen, Boye S ^a,b   Timshel, Susanne ^b   Kjeldsen, Lars ^c   Sehested, Maxwell ^b   Pyke, Charles ^a   Borregaard, Niels ^c   Danø, Keld ^a  

^a FINSEN LABORATORY   (Denmark)

^b AMAGER HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE B;

ARTICLE; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; NEUTROPHIL; PRIORITY JOURNAL; STROMA;

EID: 0030067654     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960103)65:1<57::AID-IJC10>3.0.CO;2-F     Document Type: Article

References (34)

1. BORREGAARD, N., SEHESTED, M., NIELSEN, B.S., SENGELØV, H. and KJELDSEN, L., Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood, 85, 812-817 (1995).
2. BRENNER, C.A., ADLER, R.R., RAPPOLEE, D.A., PEDERSEN, R.A. and WERB, Z., Genes for extracellular matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes Dev., 3, 848-859 (1989).
3. BROWN, P.D., Matrix metalloproteinase inhibitors: a new class of anticancer agents. Curr. Opin. Invest. Drugs, 2, 617-626 (1993).
4. CANETE-SOLER, R., LITZKY, L., LUBENSKY, I. and MUSCHEL, R.J., Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Amer. J. Pathol., 144, 518-527 (1994).
5. DANØ, K., BEHRENDT, N., BRÜNNER, N., ELLIS, V., PLOUG, M. and PYKE, C., The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis, 8, 189-203 (1994).
6. DAVIES, B., MILES, D.W., HAPPERFIELD, L.C., NAYLOR, M.S., BOBROW, L.G., RUBENS, R.D. and BALKWILL, F.R., Activity of type IV collagenases in benign and in malignant breast disease. Brit. J. Cancer, 67, 1126-1131 (1993a).
7. DAVIES, B., WAXMAN, J., WASAN, H., ABEL, P., WILLIAMS, G., KRAUSZ, T., NEAL, D., THOMAS, D., HANBY, A. and BALKWILL, F., Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res., 52, 5365-5369 (1993b).
8. DEVARAJAN, P., JOHNSTON, J.J., GINSBERG, S.S., VAN WART, H.E. and BERLINER, N., Structure and expression of neutrophil gelatinase cDNA. J. Biol. Chem., 267, 25228-25232 (1992).
9. GAMESH, S., SIER, C.F.M., HEERDING, M.M., GRIFFIGEN, G., LAMERS, C.B.H.W. and VERSPAGET, H.W., Urokinase receptor and colorectal cancer survival. Lancet, 344, 401-402 (1994).
10. GARBISA, S., D'ERRICO, A., GRIGIONI, W.F., BIAGNI, G., CAENAZZO, C., FASTELLI, G., STETLER-STEVENSON, W. and LIOTIA, L.A., Type IV collagenase augmentation associated with colorectal and gastric cancer progression. In: C.C. Harris and L.A. Liotta (eds.), Genetic mechanisms in carcinogenesis and tumor progression, pp. 203-212, Wiley-Liss, New York (1990).
11. HEWITT, R.E., LEACH, I.H., POWE, D.G., CLARK, I.M., CAWSTON, T.E. and TURNER, D.R., Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int. J. Cancer, 49, 666-672 (1991).
12. HUARTE, J., STÜTZ, A., O'CONNELL, M.L., GUBLER, P., BELIN, D., DARROW, A.L., STRICKLAND, S. and VASSALLI, J.D., Transient translation silencing by reversible mRNA deadenylation. Cell, 69, 1021-1030 (1992).
13. JEZIORSKA, M., HABOUBI, N.Y., SCHOFIELD, P.P., OGATA, Y., NAGASE, H. and WOOLLEY, D.E., Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma. Int. J. Colorect. Dis., 9, 141-148 (1994).
14. KARELINA, T.V., HRUZA, G.J., GOLDBERG, G.I. and EISEN, A.Z., Localization of 92-kDa type IV collagenase in human skin tumors: comparison with normal human fetal and adult skin. J. Invest. Dermatol., 100, 159-165 (1993).
15. KJELDSEN, L., BJERRUM, O.W., ASKAA, J. and BORREGAARD, N., Subcellular localization and release of human neutrophil gelatinase, confirming the existence of a separate gelatinase-containing granule. Biochem. J., 287, 603-610 (1992a).
16. KJELDSEN, L., BJERRUM, O.W., JOHNSEN, H.D., SEHESTED, M. and BORREGAARD, N., Human neutrophil gelatinase: a marker for circulating blood neutrophils. Purification and quantification by enzyme linked immunosorbent assay. Europ. J. Haematol., 49, 180-191 (1992b).
17. KJELDSEN, L., JOHNSEN, A.H., SENGELØV, H. and BORREGAARD, N., Isolation and primary structure of NGAL. a novel protein associated with human neutrophil gelatinase. J. biol. Chem., 268, 10425-10432 (1993).
18. MANTOVANI, A., BOTTAZZI, B., COLOTIA, F., SOZZANI, S. and RUCO, L., The origin and function of tumor-associated macrophages. Immunol. Today, 13, 265-270 (1992).
19. MIGNATTI, P., ROBBINS, E. and RIFKIN, D.B., Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell, 47, 487-498 (1986).
20. r 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res., 50, 6162-6170 (1990).
21. MORODOMI, T., OGATA, Y., SASAGURI, Y., MORIMATSU, M. and NAGASE, H., Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem. J., 285, 603-611 (1992).
22. MURPHY, G. and DOCHERTY, A.J.P., The matrix metalloproteinases and their inhibitors. Amer. J. Respir. Cell Mol. Biol., 7, 120-125 (1992).
23. NIELSEN, B.S., BORREGAARD, N., BUNDGAARD, J.R., TIMSHEL, S., SEHESTED, M. and KJELDSEN, L. Induction of neutrophil gelatinase associated lipocalin synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel disease. Gut (1995) (in press).
24. OGATA, Y., PRATTA, M.A., NAGASE, H. and ARNER, E.C., Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit chondrocytes by cotreatment with interleukin 1-beta and a protein kinase C activator. Exp. Cell Res., 201, 245-249 (1992).
25. OPDENAKKER, G., MASURE, S., PROOST, P., BILLIAU, A. and VAN DAMME, J., Natural human monocyte gelatinase and its inhibitor. FEBS J., 284, 73-78 (1991).
26. POULSOM, R., PIGNATELLI, M., STETLER-STEVENSON, W.G., LIOTTA, L.A., WRIGHT, P.A., JEFFREY, R.E., LONGCROFT, J.M., ROGERS, L. and STAMP, G.W.H., Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Amer. J. Pathol., 141, 389-396 (1992).
27. r 72,000 and 92.000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res., 52, 1336-1341 (1992).
28. PYKE, C., RALFKLÆR, E., RØNNE, E., HØYER-HANSEN, G., KIRKEBY, L. and DANØ, K., Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology, 24, 131-138 (1994).
29. PYKE, C., RALFKIÆR, E., TRYGGVASON, K. and DANØ, K., Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Amer. J. Pathol., 142, 359-365 (1993).
30. SALO, T., MÄKELÄ, M., KYLMÄNIEMI, M., AUTIO HARMAINEN, H. and LARJAVA, H., Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab. Invest., 70, 176-182 (1994).
31. STRONGIN, A.Y., COLLIER, I., BANNIKOV, G., MARMER, B.L., GRANT, G.A. and GOLDBERG, G.I., Mechanisms of cell surface activation of 72-kDa type IV collagenase. J. biol. Chem., 270, 1-8 (1995).
32. TRYGGVASON, K., HOYHTYA, M. and PYKE, C., Type IV collagenases in invasive tumors. Breast Cancer Res. Treat., 24, 209-218 (1993).
33. WAHL, S.M., ALLEN, J.B., WEEKS, B.S., WONG, H.L. and KLOTMAN, P.E., Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. nat. Acad. Sci. (Wash.), 90, 4577-4581 (1993).
34. WILHELM, S.M., COLLIER, I.E., MARMER, B.L., EISEN, A.Z., GRANT, G.A. and GOLDBERG, G.I., SV-40 transformed human lung fibroblasts secrete a 92-kDa type collagenase which is identical to that secreted by normal human macrophages. J. biol. Chem., 264, 17213-17221 (1989).